MDT Equity Research — HOLD — August 2026

Medtronic (MDT) Stock Analysis

Review

Research note — not an order or personalized advice.

Health Care

Desk command · MDT

As of

Aug 14, 2026

2 days ago

12M

HOLD

Tactical

HOLD

PM

HOLD

Desk

Full

QC

Review

Held for review

Risk not statedInvalidation not stated

Research note — not a trade. This packet is an equity-research record. It is not an order, fill, best-execution instruction, or personalized investment advice.

MDT note · Aug 14, 2026

30 min

Catalyst watch

Next material company event: fiscal Q1 2027 earnings — late-August cadence, date unconfirmed. This is the first opportunity for company-specific fundamental confirmation.

Price chart · MDT

TradingView context — not part of the rating contract.

Tactical process check · 5D

Neutral (HOLD unscored)Peer 90p
Expand

Grading rule: ages the trader TACTICAL_RATING over 5 close-to-close sessions. BUY/OVERWEIGHT is Correct when the path is > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. This is not a 12-month thesis grade · context vs SPY. Scorecard computed 2026-08-15T18:09:05.031970+00:00.

5D move

2026-08-14 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

+4.72%

Vol (20D ann.)

+19.41%

vs SPY: +4.32%

Close 91.27 (USD, vendor closes)

Batch scorecard · 2026-08-14 · MDT

Publish QC

reviewReview1 warning(s)
Expand

Pipeline fingerprint 4ce21d14d87e1d20

Trace 6d666c26

  • warning · risk

    1 programmatic risk violation(s)